NURTURING FROM THE BEGINNING
1– 4 SEPTEMBER 2013 | HILTON HOTEL SYDNEY fsaconference.com fsaconference.com
Program & Conference Overview
Conference venue
Premium partner
Hilton Sydney 488 George Street Sydney NSW 2000 Australia T +61 2 9266 2000
Conference manager and FSA Secretariat Fertility Society of Australia Annual Conference Office:
NURTURING FROM THE BEGINNING
1–4 SEPTEMBER 2013 HILTON HOTEL SYDNEY
119 Buckhurst Street South Melbourne VIC 3205 Australia T +61 3 9645 6311 F +61 3 9645 6322 E fsaconference@wsm.com.au
Further information For further information relating to the conference please download the conference app to your smart phone or tablet by scanning the qr code below:
Principal partner
dear fertility professionals
Congratulations on your decision to join us at the 2013 FSA Annual Scientific Meeting. We are certain you will not only have a valuable few days of science and education, but also an enjoyable meeting with colleagues and friends. With the host of national and international speakers and a stimulating program, Nurturing from the Beginning promises to be a great event.. This year we have a significant international faculty from the US, Netherlands, UK, China, Hong Kong and Japan. We have a number of innovations including linkages with the ASRB whose meeting is in Sydney the previous week, a session sponsored by ASPIRE with our Asian colleagues presenting and an increased exposure for posters with a 3 minute oral presentation by the ten finalists in the Poster competition.
There is no doubt that the meeting will be of major the scientific merit. Needless to say with my particular view that FSA meeting is also about the collegiality of the profession, the social events will be of the highest standard to enable attendees to enjoy each other’s company. Come prepared for the Black and White Theme for the dinner! Our goal is not only to stimulate you during our meeting but into the future! Michael Chapman Convenor
1
speakers
Keynote speakers
Invited speakers
Dr Angie Beltsos, USA
Professor Jennie Brand-Miller, Australia
Ms Sara Moser, Australia
Professor Frank Broekmans, The Netherlands
Professor John Carroll, Australia
Associate Professor Brett Nixon, Australia
Dr Mark Connolly, The Netherlands
Ms Kara Carter, Australia
Mr Stephen Page, Australia
Dr Alice Domar, USA
Dr Warren Chan, Australia
Dr Darryl Russell, Australia
Professor Susan Fisher, USA
Associate Professor Michael Davies, Australia
Dr Rebecca Spindler, Australia
Professor David Gardner, Australia
Professor Roger Hart, Australia
Professor Justin St John, Australia
Professor Geraldine Hartshorne, USA
Mr Saul Holt, Australia
Dr Olivia Stuart, Australia
Professor Jonathan Hyett, Australia
Dr Hayden Homer, United Kingdom
Professor Elizabeth Sullivan, Australia
Dr David Keefe, USA
Dr Louise Hull, Australia
Dr Georgina Tang, Australia
Professor Qiao Jie, China
Mr Alex Izurieta, Australia
Dr Patrick Western, Australia
Professor Ernest Ng, China
Dr Sonal Karia, Australia Dr Suha Kilani, Australia Mrs Alison McTavish, United Kingdom Prof Jenni Millbank, Australia
2
conference program sunday 1800 – 2000
Welcome Drinks in the Exhibition Area
Level 3
monday 0700 – 0815
Merck Sharp & Dohme Sponsored Breakfast
Level 4, Rooms 3-5
Peter Lutjen
Elonva – Local Data & Practical Considerations
0830 – 0900
Conference Welcome
Level 3, Grand Ballroom
Chairs:
Michael Chapman and Mark Bowman
0830 – 0840
Michael Chapman, Convenor
0840 – 0850 Aunty Ali Golding
Welcome from Aboriginal Elder in Residence UNSW
0850 – 0900
Mark Bowman, FSA President
0900 – 1000
Lifestyle, Mind, Body and Reproduction
Level 3, Grand Ballroom
Chairs:
Angela Beltsos and Katrina Rowan
0900 – 0920 Alice Domar
Lifestyle, Mind, Body and Reproduction
0920 – 0940
Warren Chan
Are Lifestyle Programs Worth While in the Infertile?
0940 – 1000 Jennie Brand Miller
What Diets Work?
1000 – 1030
Morning Tea, Poster Viewing and Trade Exhibition
Level 3, Exhibition Area
1030 – 1200
Concurrent Sessions
Population, Health and Getting it Right in the Lab! Handling the Patient Reproductive Outcomes Moderated by Alice Domar
Level 3, Grand Ballroom
Level 4, Rooms 1 & 2
Chairs:
Bill Ledger and Georgina Chambers
Cecilia Sjoblom and Liz Hurrell Simon Cooke
Level 4, Rooms 3 & 4
1030 – 1100 Elizabeth Sullivan Geraldine Hartshorne The Counsellor
Epidemiology of Assisted Getting It Right In The Lab! Reproductive Technology in Australia and New Zealand
1100 – 1130
Mark Connolly Justin St John The Nurse
The Economic Externalities of Assisted Reproduction
The Importance of Regulating Mitochondrial DNA During Oogenesis and Early Development
3
conference program monday continued... 1130 – 1200
Michael Davies Suha Kilani The Organisation
How Safe is ART at a Population Level
1200 – 1300
Lunch, Poster Viewing and Trade Exhibition
Level 3, Exhibition Area
1200 – 1300
REACT Group SIG Meeting
Level 4, Room 5
1300 – 1430
Keynote Presentation
Level 3, Grand Ballroom
Chairs:
Mark Bowman and Peter Benny
Improving Lab Standards to Avoid Fluctuations
1300 – 1340 David Gardner
Ian Johnston Memorial Lecture – Nurture of the Human Preimplantation Embryo
1340 – 1405 Susan Fisher
SRB FSA Lecture
1405 – 1430
Frank Broekmans
AMH: Where are We Now?
1430 – 1500
Afternoon Tea, Poster Viewing and Trade Exhibition
Level 3, Exhibition Area
1500 – 1730
Concurrent Sessions 1
Clinical Scientific
Concurrent Sessions 2
Level 3, Grand Ballroom
Chairs:
Roger Hart and Geraldine Hartshorne Frank Broekmans
Level 4, Rooms 1 & 2
Concurrent Sessions 3
Psychosocial / Nursing Level 4, Rooms 3 & 4
Alice McTavish and Sandra Kennedy
1500 – 1515
Paul Atkinson Shlomi Barak
Paula Scanlon
A ‘Freeze All’ Strategy for Avoidance of Ovarian Hyperstimulation Syndrome in High Risk Patients treated with GnRH Antagonist Controlled Superovulation for IVF: Pregnancy Rates and Risk of OHSS
Is Oocyte Mechanical assisted Activation an Effective Approach for Treating Patients with poor Fertilisation Rates from Standard ICSI?
Nursing Management of Ovulation Induction in a Fertility Program
1515 – 1530
Mark Bowman
Peter Coleman
Kerry Hampton
Does FSH Dose Adversely Blastocoelic Fluid may contain Informing the Development of a Influence Embryo Aneuploidy? Embryonic DNA that could be New Model of Care to Improve Data from CGH cycles used for Preimplantation the Fertility-awareness of at Genea Genetic Diagnosis (PGD) Sub-fertile Women in Primary Health Care 1530 – 1545 Don Leigh David Edgar Louise Harper
4
Blastocyst Biopsy of Human Embryos Improves Implantation and Live Birth Rates compared to Day Three Biopsy – Analysis of ANZARD Database 2004 to 2008
Blastocyst Formation can be Predicted from the Optimal Timing of Nuclear Envelope Breakdown (NEBD) Identified using Time-lapse Images
Late Miscarriage and Stillbirth – Why Should We Care?
1545 – 1600
Michael Costello Nerupi Fernando Vanessa Raggio
The Effect of Polycystic Ovaries on IVF/ICSI Treatment Outcome
1600 – 1615
Cindy Farquhar Debra Gook Louise Johnson
A Randomized Controlled Trial of Fallopian Tube Sperm Perfusion compared with Standard Intrauterine Insemination for Women with Non-tubal Infertility
Comparable Outcomes from Vitrified and Slow Frozen Blastocysts Frozen on Day 5 and 6 Impact Of Oxygen On In Vitro Development And Metabolism Of Mouse Preantral Follicles
Patient Uptake of Version III Clinical Culture Media Suite Trial – A Clinic by Clinic Comparison Evaluation of Your Fertility, A Public Education Campaign to Increase Fertility Knowledge
1615 – 1630
Claire Garrett Eliza Krisman Elizabeth Hurrell
Do Serum Anti-Mullerian Hormone (AMH) Levels Indicate Significant Protection of Ovarian Reserve in Oncology Patients Who Use Gonadotrophin Releasing Hormone Analogue (Gnrha) During Chemotherapy?
Does The Sex of Reciprocal Translocation Carriers Influence Blastocyst Development and PGD Outcomes?
Comparative Study of Experiences of Miscarriage
1630 – 1645 John McBain Liza Tilia Nadia Mellor
What is the Objective Evidence to Support Freezing All Embryos Generated in a Stimulation Cycle for Transfer in a Subsequent Natural or Artificial Thaw Cycle to Improve the Chance of Successful Implantation?
1645 – 1700 Sameer Jatkar
The Link between Oocyte Spindle Normality and Resulting Embryo Euploidy
Enhancing Change in Lifestyle, Mind and Body in Infertility
Petra Wale Iolanda Rodino
Progesterone Level on day Abnormal Developmental of HCG Trigger and IVF Cycle Patterns Observed with Outcomes Time-lapse Imaging
Disordered Eating Attitudes and Behaviours in Women Undergoing Fertility Treatment in Western Australia
1700 – 1715 Genia Rozen Leeanda Wilton
Marianne Tome
Reproductive Outcomes Preimplantation Genetic Following Heterotopic Diagnosis of Aneuploidy Transplantation: (PGD-A) and Transfer of Royal Women’s Hospital Euploid Embryos in Women Experience of Advanced Maternal Age (AMA)
Keeping Up With The Ever-evolving Psycho-Social Aspects of Treatment: One Clinic’s Way of Ensuring a Considered Multi-Disciplinary Approach to Decision Making on Complex Patient Presentations
1715 – 1730
Catharyn Stern Tristan Hardy
Margaret Van Keppell
First Reported Pregnancy from Heterotopic Grafted Frozen Ovarian Tissue after Bilateral Oophorectomy
Nurturing the Best Interests of the Child
Real-time three-dimensional Imaging of Embryos using Digital Holographic Microscopy
1730 – 1745 Yan Wu IVF Treatment Of Oncological Patients – A Retrospective Study From Westmead Fertility Centre (WFC) 1800 – 1830
FSA Annual General Meeting
Level 3, Grand Ballroom
5
conference program tuesday 0700 – 0815
Ferring Pharmaceuticals Sponsored Breakfast
Level 4, Rooms 3-5
Claudio Wolfenson and Pascal Danglas
Gonadotropins in ART – Past, Present and Future Perspectives / The evolution of Gonadotropin preparations – How far have we come? Gonadotropins in ART – What does the Future Hold?
0815 – 0845
Keynote Presentation
Level 3, Grand Ballroom
Chairs:
David Keefe and Leeanda Wilton
0815 – 0845 Jonathan Hyett
Fetal DNA – The Latest on Prenatal Testing
0845 – 1000
Keynote / Invited Speaker Presentations
The Oocyte
Moral & Ethical Dilemmas
Level 4, Rooms 1 & 2
Level 3, Grand Ballroom
0845 – 0910 John Carroll Jenni Millbank
Organization and Inheritance of Mitochondria in Oocyte Maturation
Rethinking Commercial Surrogacy in Australia
0910 – 0935 David Keefe Stephen Page
Spindle Abnormalities in the Human Oocyte
Surrogacy: Moral and Ethical Dilemmas
0935 – 1000 Hayden Homer Saul Holt
The Control of Meiosis in Mammalian Oocytes
1000 – 1100
Poster Presentations
Clinical Scientific Nurses / Counsellors
Level 3, Grand Ballroom
Chairs: Clare Boothroyd
Level 4, Rooms 1 & 2
Level 4, Rooms 3 & 4
Cecilia Sjoblom and Phillip Matson
Kate Bourne and Sandra Kennedy
1100 – 1130
Morning Tea, Poster Viewing and Trade Exhibition
Level 3, Exhibition Area
1100 – 1130
LIGHT Group SIG Meeting
Level 4, Room 5
6
Posthumous Sperm Donation – The Legalities
1130 – 1330
Concurrent Sessions 1
Clinical Scientific
Concurrent Sessions 2
Concurrent Sessions 3
Psychosocial / Nursing
Level 3, Grand Ballroom
Level 4, Rooms 1 & 2
Level 4, Rooms 3 & 4
Chairs:
Neil Johnson and Gavin Sacks
Keith Harrison and John Tyler
Evelyn Zwahlen and Jane Early
1130 – 1145
Mark Bowman Vi-Khiem Hua
Michael Legge
Australian Couples Travelling Volatile Organic Compounds Understanding the New Zealand Overseas for Social Sex Selection: within the IVF Laboratory Public Debates over Genetic One Units Experience Testing: An Interdisciplinary Approach 1145 – 1200 Natasha Pritchard De-Yi Liu
Carmel Carrigan
Criteria Used by Recipients in Semen Donor Selection
A Case Control Study of Antioxidant Therapy In Patients With Multiple Failed IVF Cycles
A Simple and Effective Method for Human Sperm Cryopreservation
1200 – 1215 Rachael Knight Nicole Martin Angela Ferguson
New Options for Conception in HIV Sero-discordant Couples. A Review of 10 years Experience at the Royal Women’s Hospital Melbourne and Presentation of Future Treatment Protocols.
Structural Abnormalities of the Y Chromosome in Males Presenting with Infertility
Embryo Donation Network: Working Towards Informed Choice in Australia
1215 – 1230 Elizabeth Sullivan
Phillip Matson Leo Leader
The Relationship Between Semen Quality And The Halosperm G2 Kit Results
Pregnancies and Births following Assisted Reproductive Technology in Australia, 1979 – 2011
Changing Attitudes of Parents of Donor Insemination Children to Disclosure
1230 – 1245
Zhuoyang Li Ashleigh McEvoy
Kate Bourne
Birthweight Percentiles by Gestational Age for Births Following Assisted Reproductive Technology in Australia and New Zealand, 2002 – 2010
Consultation with Donors who Donated Gametes in Victoria, Australia before 1998: Access by Donor-conceived People to Information about Donors
1245 – 1300 Sarah Johnstone
Air-drying is a Viable Method of Semen Storage prior to Testing Sperm DNA Fragmentation with the Halosperm G2 kit.
Maria Diamente Suellen Peak
Microsurgical TESE: The Final Oocyte Vitrification: Results The Donor Embryo Program at Frontier in the Search for Sperm and Clinical Outcomes Melbourne IVF: Development and Implementation of a Unique Program Model to Facilitate Embryo Donation 1300 – 1315 Larisa Corda Helana Shehadeh Antonia Lockitch
Sociodemographic Factors and Birth following Assisted Reproductive Technology (ART) Treatment in Australia, 2007 – 2009, a Population Study
Paternal Obesity Impairs the Reproductive Health and Ovarian Molecular Profile of their Female Offspring
1315 – 1330
Michele Hansen
Kelli Sorby Antonia Lockitch
ARTand Birth Defects in What the SNPs are Telling Us Western Australia – PGS Using SNP Arrays
From Choice To Expectation: Accessing The World Egg Bank Patients’ Perspective
Trauma Or Pleasure: The Love Hate Relationship Of Donor Sperm
7
conference program tuesday continued... 1330 – 1430
Lunch, Poster Viewing and Trade Exhibition
Level 3, Exhibition Area
1330 – 1430
Fertility Preservation SIG Meeting
Level 4, Room 5
1430 – 1545
Concurrent Session
CREI Presentations Scientific Nursing – Comparing ART
Concurrent Session
Concurrent Session
Level 3, Grand Ballroom
Level 4, Rooms 1 & 2
Level 4, Rooms 3 & 4
Chairs:
Clare Boothroyd and Angela Beltsos
Hayden Homer and Phillip Matson
Jan MacKenzie and Donna Close
1430 – 1455
Warren Chan
Patrick Western Alison McTavish
Endometrial “Scratch” – Another Advance?
Germline Development and the Male Epigenome
Fertility Nursing in the UK
1455 – 1520 Alex Izurieta Darryl Russell Sara Moser Should We Help Older Women Conceive?
Relationships Between Cumulus Cells and Oocytes Assuring Embryo Developmental Potential
IVF in the Kingdom
1520 – 1545 Olivia Stuart Brett Nixon
Kara Carter
Elevated Progesterone in the Late Follicular Phase in IVF?
Comparing ART
1545 – 1615
Afternoon Tea, Poster Viewing and Trade Exhibition
Level 3, Exhibition Area
HSPA2 and Unexplained Failure of Fertilization in IVF
1545 – 1615
RTAC COP Review Information Session
Keith Harrison
Level 4, Rooms 1 & 2
1615 – 1715
ASPIRE – FSA Joint Session
PCOS
Level 3, Grand Ballroom
Chairs:
Rob Norman and Michael Costello
1615 – 1635 Jie Qiao
PCOS in Asian Patients
1635 – 1655 Ernst Ng
Ultrasound Diagnosis of Polycystic Ovary Syndrome
1655 – 1715 Roger Hart
Diagnosis of PCOS in Adolescents
1900
Conference Dinner
Doltone House, Pyrmont Bay
8
wednesday 0900 – 1030
Concurrent Session
Concurrent Session
Clinicians and Scientists
Counsellors/Nurses
Level 3, Grand Ballroom
Micro RNAs – For Dummies
Level 4, Rooms 1 & 2
Cross Cultural Impact of Infertility Panel Discussion
0900 – 0930 Tamer Nafee Suha Kilani
MicroRNAs and Reproduction
0930 – 1000 Louise Hull Georgina Tang
MicroRNAs and Implantation
1000 – 1030
Peter Stanton Sonal Karia
MiRNAs and Spermatogenesis
1030 – 1100
Morning Tea, Poster Viewing and Trade Exhibition
Level 3, Exhibition Area
1100 – 1200
Invited Session Non Human IVF
Level 4, Rooms 1 & 2
Level 4, Rooms 3 & 4
1100 – 1130 ESHRE Exchange Speaker, Souraya Jaroudi Dr Rebecca Spindler
Assessment of Telomere DNA Length in Human Oocytes and Cleavage Stage Embryos: Impact on Aneuploidy Risk and Implantation Potential
Two Legs or Four: Propagating Valuable Embryos
1130 – 1200 Geraldine Hartshorne
Telomere Lengths in Human Gametes and Embryos
1200 – 1230
Keynote Lecture
Level 3, Grand Ballroom
Angela Beltsos
Nurturing from the Beginning
1230 – 1315
Lunch, Poster Viewing and Trade Exhibition
Level 3, Exhibition Area
1315 – 1400
Invited Session: Late Breaking Advances
Level 3, Grand Ballroom
1400 – 1500
Invited Session: Presidents Debate
Level 3, Grand Ballroom
1500
Conference Closes
Level 3, Grand Ballroom
Program is subject to change without notice
9
conference supporters Premium partner
Conference smart app supporter
Education partner
Principal partner
Conference satchel supporter
Scientific program supporter
Education partner
Scientific program supporter
Sponsored breakfast
Scientific program supporter
Conference namebadge and lanyard supporter
10
Sponsored breakfast
conference events
social functions
breakfast symposiums
Welcome Reception
Monday 2 September 2013 0700 – 0830
Tuesday 3 September 2013 0700 – 0830
Room 3 & 4, Level 4 Hilton Hotel Sydney
Room 3 – 5, Level 4 Hilton Hotel Sydney
Elonva – Local Data & Practical Considerations
Gonadotropins in ART – Past, Present and Future Perspectives
Associate Professor Peter Lutjen, Medical Director for Monash IVF
The evolution of Gonadotropin preparations – How far have we come?
Sunday 1 September 2013 1800 – 2000 Conference Exhibition, Hilton Hotel Sydney The Welcome Reception will be held in the Exhibition Area at Hilton Hotel.
Conference Dinner Tuesday 3 September 2013 1900 – 2300 Doltone House, Pyrmont Bay Enjoy an evening with colleagues and friends at the unique heritage venue, Doltone House. Located at the historic Jones Bay Wharf with a spectacular waterfont view, Doltone house is the perfect location and promises guests a night to remember at this year’s FSA Conference Dinner.
Prizes Prizes will be announced at the Conference Dinner on Tuesday evening. Best Clinical Paper BFS Exchange Award Best Scientific Paper ESHRE Exchange Award Best Paper by a Nurse Education Prize Best Psychosocial Paper Education Prize
Associate Professor Peter Lutjen is the Medical Director at Monash IVF In this symposium, Assoc. Prof Lutjen will share some of the practical considerations involved in successfully incorporating ELONVA (corifollitropin alfa) into daily clinical practice. From dose and patient selection, timing of scans, managing weekend pick-ups, dispensing and top-up doses, this session will look at the organizational and practical considerations taken to minimize the impact on the clinic. Assoc. Prof Lutjen will also share some of the local experience following integration of ELONVA, along with local data in different patient groups, including women of advanced reproductive age.
Gonadotropins in ART – what does the future hold? Dr Claudio Wolfenson, Director of Production and Regulatory Affairs Instituto Massone SA Dr Pascal Danglas, Executive Vice President, Clinical & Product Development.
ELONVA is the first sustained follicle stimulant available in Australia and replaces the first seven injections of conventional FSH with one injection. It is available on the Pharmaceutical Benefits Scheme as a Section 100 item for use in women undergoing IVF/ICSI in an antagonist protocol with an antral follicle count less than 20.
Best Poster Presentation Education Prize
11
ePoster zone ePosters will be on display for the duration of the Conference
1 Franca Agresta A Growing Preference For Oocyte Rather Than Embryo Cryopreservation As A Fertility Preservation Option for Oncology Patients 2 Bonnie Anderson Higher pregnancy rates in FET program utilising a unique HRT regimen 3 Susan Arentz The use of complementary medicine (CAMs) and self help measures by women with polycystic ovary syndrome (PCOS) 4 Hamish Barblett The Use of Endometrial Sampling to Improve Outcomes for Patients with Recurrent Implantation Failure 5 Julianne Benson Early Embryo Development and Implantation are Independent of Culture Media System: A Sibling Oocyte Study 6 Clare Boothroyd Using image capture when double checking is required with a single embryologist: an economic option 7 Ron Chang Clinical Outcome following Mild Ovarian Stimulation for IVF 8 Oswaldien Claassens Storage of Sperm Samples at Room Temperature for DNA Fragmentation Testing 9 Christopher Copeland A comparison of men’s responses to surgical sperm retrieval with women’s responses to transvaginal oocyte retrieval for in-vitro fertilisation (IVF) 10 Larisa Corda Patient acceptance of long acting follicle stimulating preparations when undergoing IVF 11 Kristy Demmers The Effects of Vaginal Lubricants on Sperm Function: an in vitro analysis
12
12 Maria Diamente Implementation of an Electronic Witness System into an Established IVF Laboratory 13 Herman Fernandes Thaw and Culture of Cleavage Stage Embryos to Blastocyst and Transfer Significantly Increases the Pregnancy and Live Birth Rate 14 Peter Field CFTR Mutation Screening in Male ART Patients 15 Emily Fiske Are Antagonist Protocols Less Optimal for use in Satellite IVF Clinics? 16 Emily Fiske Utilisation of ART in Single Women and Lesbian Couples Since the 2010 Change in Victorian Legislation 17 Michelle Fraser Cross-compatibility of Single Cell Analysis Platforms 18 Stacey Gwilym A comparison of early developmental markers in human embryos fertilized by ICSI and standard IVF, using time-lapse monitoring 19 Keith Harrison Effect of Male Age on the Incidence of Sperm Aneuploidy 20 Gillian Homan The challenges associated with promoting healthy lifestyle change in infertile couples 21 Fabrizzio Horta Decrease of DNA sperm fragmentation in sperm selected by Magnetic Activated Cell Sorting (MACS) in samples with clinical purposes 22 Tamara Hunter A Prospective Observational Study of the Effect of Ovarian Cystectomy on Ovarian Reserve (SOCOR)
23 Jacquelyn Irving Use of AMH as a predictor of twin pregnancy 24 Robert Lahoud PCOS and IVF: Defining phenotypes: Slim vs. Overweight 25 Indu Lata Predictors of Ovarian Reserve, What is best 26 Wei Li Is the decrease in ovarian reserve following laparoscopic surgery for endometriomata due to the procedure of cystectomy or the adhesive feature of endometriosis? 27 Dave Listijono Is Measurement of Progesterone prior to FSH Stimulation useful in Antagonist Cycles? 28 Farhana M.Rafik Fresh ET. Does the days really matter? 29 Alan Macaldowie Assisted reproductive technology in Australia, 2002-2011 30 Ann Mangalaraj Epidemiological Aspects of Infertile Couples with Azoospermia in a Tertiary Care Setup in South India 31 Nicole Marjanovich Comparison of Day 5 and Day 6 Vitrified Blastocyst using the Cryotop Method and Hormone Replacement Therapy (HRT) Treatment 32 Anthony Marren Does the degree and speed of blastocoele re-expansion after cryopreservation and warming correlate with pregnancy rates: a retrospective cohort study 33 Phillip Matson Can We Trust Makler Chambers? 34 Simon McDowell Incidence of antisperm antibodies amongst 1085 semen samples from couples presenting with infertility
35 Luke McLindon Luteal phase defect; in women with unexplained subfertility 36 Monika McShane Reproducibility Of Anti Mullerian Hormone (AMH) Results Is Improved By Pre-mixing Samples With Assay Buffer When Using The Beckman Coulter Gen II Assay 37 Lim Mui Nee A Comparison between Pregnancy and Take Home Babies Rates in Regulated and Natural FrozenThawed Embryo Transfer Cycles 38 Andrew Noble Use of refrozen donor sperm in IVF and ICSI 39 Robert Norman Ovulation induction should remain first line treatment in patients with PCOS and hypothalamic dysfunction (WHO anovulatory infertility group I and II) 40 Jeremy Osborn Basal serum AMH concentrations predict ovarian response and pregnancy outcome during ART cycles but not early cleavage and embryo quality 41 Timothy Rabbitt Comparison of the Seaforia™ Sperm Preparation system with Density Gradient Sperm Preparation
45 Caroline Smith Attitudes to research: the views of reproductive medicine clinicians, nurses and counselors
52 Stephanie Sullivan Does quality matter? A retrospective analysis of single vitrified blastocyst transfers
46 Caroline Smith Acupuncture practices for infertility in Australia and New Zealand
53 Elizabeth Sullivan A stable sex ratio at birth in Australia between 1991 and 2010
47 Melissa Stemp The effect of the reproductive status of women upon the serum concentrations of three markers for breast cancer, CA15-3, CA72-4 and S-100
54 Alon Talmor The Monash IVF Experience with Corifollitropin alfa
48 Melissa Stemp Performance characteristics of Roche automated immunoassays used to measure CA125, PAPP-A, free hCG, tPSA, CA15-3, CA72-4, CA19-9, CYFRA21, NSE, PCT and S-100
55 Jane Wolyncevic Relationship of Blood Group with Ovarian Reserve and Response to Superovulation 56 John Yovich Validation of the PIVET rFSH targeted stimulation protocol
49 Melissa Stemp Prostate specific antigen (PSA) measured in women at different stages of the reproductive cycle
57 Tatiana Zandanova Signalling Mechanisms in Human Ectopic Pregnancy: A New Approach to Study of the Pathogenesis of Failed Implantation
50 Melissa Stemp The changes in serum CA-125 and PAPP-A during natural and stimulated ovarian cycles and early pregnancy
58 Nadia Zulbahary Comparison of Outcome of Fresh Embryo Transfer using Frozen Sperm Retrieved by MESA, TESE and TESA
51 Olivia Stuart In the beginning there was ovulation induction‌ and it still has a place: 13 years of experience
42 Itziar Rebollar-Lazaro Total Fertilisation Failure after IVF insemination. Is this nurturing from the beginning or poor clinical practice? 43 Sandeep Sahu What is Ideal Anaesthesia for assisted reproductive techniques 44 Kalyani Sivendran Zona Pellucida Bound Sperm for ICSI Improves Implantation and Clinical Pregnancy Rate in Couples with Persistent Poor Outcomes in Previous Conventional ICSI Cycles
13
exhibitors MSD Booth 22-25
Merck Serono Booth 5-11
Avant Insurance
Bayer Healthcare
BlueGnome
Booth 19
Booth 14
Booth 2
Cook Medical
European Sperm Bank USA
Ferring
Booth 27-28
Booth 1
Booth 26 & 29
Gytech
Insight
Key IVF Supplies
Booth 15-16
Booth 12
Booth 4
14
ORIGIO Australasia
Perrigo Australia
Primaco
Booth 17
Booth 3
Booth 33
Regional Health Care Group
Sonologic
The Pipette Company
Booth 35
Booth 20-21
Booth 13
Thermo Fisher Scientific
The World Egg Bank
UNSW Master Rep Med
Booth 34
Booth 30
Booth 31
Vitrolife
Fertility Coalition
bioMĂŠrieux
Booth 18
E x h i b i t i o n D i s p l ay T a b l e 1
E x h i b i t i o n D i s p l ay T a b l e 2
15
general information
Certificate of Attendance
Delegate list
Registration desk operating hours
Following the Conference all registered attendees will receive a Certificate of Attendance from the Fertility Society of Australia. Certificates will be issued electronically.
The Delegate List contains the name, organisation and state / country of origin of registered delegates and exhibitors that have elected to be listed. You may find that someone you know is not on the delegate list and this maybe because they have elected to with withhold their name due to privacy.
Sunday 1 September 2013 1200 – 2000 hrs
Climate and dress code September in Sydney is the first month of Spring with temperatures becoming warmer at approximately 11 to 19 degrees celcius.
Disclaimer FSA 2013 Conference including the Fertility Society of Australia annual Conference organisers, will not accept liability for the damages of any nature sustained by participants or their accompanying persons for the loss or damage to their personal property as a result of Conference and exhibition or related events. All details contained in this handbook are correct at the time of printing.
Welcome Reception Smart casual Conference Sessions Smart casual Conference Dinner Black and white / cocktail
CDP points This meeting has been approved as a RANZCOG Approved O&G Meeting and eligible Fellows of this College will earn CPD points for attendance as follows: Full Attendance (all days)
Insurance
22
Attendance Monday
8
Attendance Tuesday
8
Attendance Wednesday
6
Daily catering Morning tea, lunch and afternoon tea will be served daily in the Exhibition area.
Delegates are strongly advised to secure appropriate travel and health insurance. Delegate registration fees do not provide any insurance coverage. The Organising Committee and the Conference Office accept no responsibility for any loss in this regard nor accept the liability for the damages of any nature sustained by participants or their accompanying persons for loss or damage to their personal property as a result of the Conference and exhibition or related events.
Internet access WIFI internet access will be provided for all conference delegates. Please see the Registration Desk for login details.
16
Monday 2 September 2013 0700 – 1730 hrs Tuesday 3 September 2013 0730 – 1730 hrs Wednesday 4 September 2013 0800 – 1500 hrs
Speakers’ preparation room The Speaker Preparation Room located on Level 3 of the Hilton Hotel. Sunday 1 September 2013 1200 – 1800 hrs Monday 2 September 2013 0730 – 1730 hrs Tuesday 3 September 2013 0730 – 1700 hrs Wednesday 4 September 2013 0730 – 1500 hrs
Special requirements Every effort will be made to ensure delegates with special needs are catered for. To assist us with ensuring your attendance at Congress is a pleasant and comfortable one please specify any special requirements when registering.
Time zone Sydney’s time zone is UTC/GMT +10 hours.
notes
notes